Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Precipio, Inc. Common Stock (PRPO)

Laboratory Analytical Instruments

https://www.precipiodx.com

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

12325 EMMET ST
OMAHA, NE

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/18/2000

Market Cap

8,262,875

Shares Outstanding

1,420,000

Weighted SO

1,420,125

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

BDSX --.--%

SERA --.--%

APDN --.--%

OLK --.--%

CDNA --.--%

CSTL --.--%

TWST --.--%

NTRA --.--%

HTGM --.--%

Beta

1.4120

Last Div

0.0000

Range

4.31-8.99

Chg

0.1750

Avg Vol

7683

Mkt Cap

8262875

Exch

NASDAQ

Country

US

Phone

203 787 7888

DCF Diff

7.0388

DCF

-0.3688

Div Yield

0.0000

P/S

0.5184

EV Multiple

-1.8192

P/FV

0.6735

Div Yield %

0.0000

P/E

-2.1309

PEG

-0.0368

Payout

0.0000

Current Ratio

0.7321

Quick Ratio

0.5900

Cash Ratio

0.2783

DSO

25.3485

DIO

23.6618

Op Cycle

49.0103

DPO

30.9813

CCC

18.0289

Gross Margin

0.3681

Op Margin

-0.3504

Pretax Margin

-0.2402

Net Margin

-0.2402

Eff Tax Rate

0.0021

ROA

-0.2211

ROE

-0.2931

ROCE

-0.4390

NI/EBT

1.0000

EBT/EBIT

0.6856

EBIT/Rev

-0.3504

Debt Ratio

0.0378

D/E

0.0540

LT Debt/Cap

0.0075

Total Debt/Cap

0.0512

Int Coverage

797.8570

CF/Debt

-1.4511

Equity Multi

1.4295

Rec Turnover

14.3993

Pay Turnover

11.7813

Inv Turnover

15.4257

FA Turnover

10.2640

Asset Turnover

0.9204

OCF/Share

-0.6484

FCF/Share

-0.7455

Cash/Share

0.8739

OCF/Sales

-0.0595

FCF/OCF

1.1496

CF Coverage

-1.4511

ST Coverage

-1.6886

CapEx Coverage

-6.6831

Div&CapEx Cov

-6.6831

P/BV

0.6735

P/B

0.6735

P/S

0.5184

P/E

-2.1309

P/FCF

-7.5737

P/OCF

-8.5977

P/CF

-8.5977

PEG

-0.0368

P/S

0.5184

EV Multiple

-1.8192

P/FV

0.6735

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 11, 20:30 Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless GlobeNewswire Inc. Mar 17, 21:00 Precipio Announces Q4 and year-end 2024 Shareholder Update Call GlobeNewswire Inc. Jan 17, 10:30 Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan GlobeNewswire Inc. Dec 14, 16:30 Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 GlobeNewswire Inc. Nov 16, 17:00 Precipio Announces Q3-2023 Shareholder Update Call

Revenue Product Segmentation